We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA Commissioner Stephen Hahn said Friday that the agency will resume domestic inspections this month using a new risk assessment system developed in response to the pandemic. Read More
Even in the midst of the COVID-19 pandemic, some drugmakers have continued to impose price hikes, raising the list prices for 42 branded drugs by an average of 3.5 percent in July so far, according to a drug price watchdog. Read More
